CD20 (N) (4-6H:2C) Anti-Human Mouse IgG MoAb

抗CD20单克隆抗体

Rituximab used for treatment of lymphoma is an antibody drug of which target is pan-B cell marker, CD20. It has been reported that the C-terminal region of CD20 undertakes a critical role in a binding to rituximab and the association between C-terminal mutations and rituximab-resistance has been investigated. This antibody was developed as a new monoclonal antibody that recognizes the N-terminal region of CD20 molecule to detect comprehensive CD20 regardless of C-terminal mutations. It is expected to be useful for the detailed examination of CD20 molecules by adding this antibody to reserch of CD20.
价格: 3257.1元
  • Buy 5 for ¥3094.25 each and save 5%
  • Buy 21 for ¥2931.39 each and save 10%
  • Buy 31 for ¥2768.54 each and save 15%
  • Buy 51 for

基本信息

数据文档 查看数据文档
货号 MA01151
规格 100 μg
宿主 Mouse
免疫原 Synthetic peptide of the N-terminal part of human CD20 (CMQSGPKPLFRRMSS).
特异性
亚型 IgG3
反应性 Human
克隆 4-6H:2C
Uniprot
浓度 Please see datasheet.
推荐稀释度
配方 Lyophilized product from 1.0 mL of PBS containing 1 % BSA and 0.05 % NaN3
应用范围 IHC, WB.
别名
保存条件 冻干产品: 2 - 8°C保存5年; 液体: -20°C保存2年.
注意 仅用于科学研究, 不能用于疾病诊断.

©2024 武汉天正源生物科技有限公司版权所有. SiteMap